Horio Takamasa

Partner

Takamasa Horio

Print profile

Languages
JapaneseEnglish

Contact Information

TEL
+81-3-6266-8781
FAX
+81-3-6266-8681

Practice Areas

Takamasa Horio:Awards

Awards
Top rankings received from Chambers Asia-Pacific 2024
Awards
Top rankings received from asialaw 2023-24
Awards
The Best Lawyers in Japan™ and Best Lawyers: Ones to Watch in Japan™ (2024 edition)

View All

Takamasa Horio:News

Public Service
Takamasa Horio becomes a Research Collaborator for "Research for Revision of the Guidelines on Whether Programs Constitute Medical Devices," Health Labour Sciences Research
Public Service
Takamasa Horio becomes a Research Collaborator for the "Research and Study on Enhancing Pharmacists' Operations Dealing with Property and People in a Society with Interconnected Communities," Health Labour Sciences Research
Public Service
Takamasa Horio became a member of Planning Committee on Educational Materials for Ongoing Seminars, Japan Association for the Advancement of Medical Equipment

View All

Takamasa Horio:Seminars

Nov. 11, 2019External Seminars
"16th DIA Japan Annual Meeting 2019 ""How MA/MSL should be?""
Nov. 11, 2019External Seminars
"16th DIA Japan Annual Meeting 2019 "A Practical Approach to the Guidelines on Pharmaceutical Product Communications""
Nov. 12, 2018External Seminars
"15th DIA Japan Annual Meeting 2018 "Guidelines on Pharmaceutical Product Communications""

View All

Takamasa Horio:Publications

Book
"MR Textbook 2024"
Magazine Article
"Chambers Global Practice Guides Medical Cannabis and Cannabinoid Regulation 2023 - Japan Trends and Developments"
Magazine Article
"Medical Digital Transformation: Latest Trends in Developing Digital Medical Services and Related Knowledge (13) - Legal Considerations Concerning Medical Applications of AI; Discussions about Foundational Matters for Further Development"

View All

Takamasa Horio:Other

Background

  • Doshisha University (LL.B., 2006)
  • Kyoto University Law School (J.D., 2008)
  • Northwestern University Pritzker School of Law (LL.M. with honors, 2016)
  • Kellogg School of Management (Certificate in Business Administration, 2016)
  • with Jenner & Block LLP, Chicago (2016-2017)
  • seconded to the Pharmaceutical Safety and Environmental Health Bureau (Compliance and Narcotics Division, Pharmaceutical Evaluation Division, and Medical Device Evaluation Division) of the Ministry of Health, Labour and Welfare (as Legal Adviser)(2017-2020)

Major Activities

  • Member of the Exploratory Committee on Promotion of Remanufactured SUD for the Project to Establish Remanufactured SUD Standards, Ministry of Health, Labour and Welfare(2020-)
  • Member of Review Committee for Study Regarding Pharmaceutical Regulations on Medical Equipment Programs Utilizing Artificial Intelligence and Other Advanced Technology, Japan Agency for Medical Research and Development(2020-)
  • Member of Study Group on Countermeasures against Cannabis and Other Drugs, Ministry of Health, Labour and Welfare(2020-)
  • Member of the Advisory Committee (Advisory Committee on Manufacture and Quality Control of Pharmaceutical Products) for Toyama Pharmaceutical Affairs Council (2021-)
  • Adviser for The Japan Federation of Medical Devices Associations (2021-)
  • Member of the Toyama Prefecture GMP Inspection Investigative Committee (2021-)
  • Contributed to Research for Identifying Issues Relating to Determinations on Whether Programs Constitute Medical Devices Based on International Consistency, a Special Scientific Research Project Sponsored by the Ministry of Health, Labour and Welfare (2021-2022)
  • Outside Member of the "Evaluation Committee on the Technical Proposal for Network Service Dedicated to Information Exchange on Medical Products," Ministry of Health, Labour and Welfare (2022-)
  • Member of Planning Committee on Educational Materials for Ongoing Seminars, Japan Association for the Advancement of Medical Equipment (2022-)
  • Research Collaborator for the "Research and Study on Enhancing Pharmacists' Operations Dealing with Property and People in a Society with Interconnected Communities," Health Labour Sciences Research (2023-)
  • Member of Legislation Committee, Japan Pharmaceutical Association (2022-)
  • Research Collaborator for "Research for Revision of the Guidelines on Whether Programs Constitute Medical Devices," Health Labour Sciences Research (2023-)

Practice Group

  • Healthcare Practice Group
  • M&A Practice Group

Bar Admissions

admitted in Japan, 2009; Illinois, 2016
Daini Tokyo Bar Association